Speaker Detail

John Reed is CEO of Sanford-Burnham Medical Research Institute, with more than 1,200 employees and operations in San Diego and Santa Barbara, Calif., and in Orlando, Fla. Reed's research contributions encompass a broad range of therapeutic areas, including oncology, autoimmunity/inflammation, infectious diseases and diabetes. He is a pioneer in delineating the fundamental mechanisms that regulate programmed cell death ("apoptosis"), a process by which cells in the body "commit suicide" through activation of a genetically controlled program. Reed is author of over 800 peer-reviewed scientific articles and more than 50 book chapters. He is the recipient of numerous honors for his research accomplishments and has been awarded more than 100 research grants by government and non-government funding agencies. He serves or has served as an advisor and consultant to numerous biotechnology and pharmaceutical companies, and on the boards of several public biopharmaceutical companies.